As of June 10, 2025, GamaLife (BTRVB.LS) has a market cap of $5.70 billion USD. According to our data, GamaLife is ranked No.2527 in global market value.
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() AbbVie
ABBV
|
$334.73 B |
-0.012 M
|
![]() USA
|
![]() Amgen
AMGN
|
$157.78 B |
0.004 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.69 B |
0.002 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$724.64 B |
0.021 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$376.43 B |
-0.005 M
|
![]() USA
|
![]() Merck
MRK
|
$204.27 B |
-0.000 M
|
![]() USA
|
![]() Novartis
NVS
|
$234.51 B |
0.300 B
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$138.15 B |
-0.008 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$56.52 B |
0.951 B
|
![]() USA
|
![]() Sanofi
SNY
|
$123.53 B |
2.139 B
|
![]() France
|
![]() Gilead Sciences
GILD
|
$136.94 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$84.17 B |
0.483 B
|
![]() UK
|
![]() AstraZeneca
AZN
|
$229.53 B |
0.622 B
|
![]() UK
|
![]() Biogen
BIIB
|
$19.85 B |
-0.001 M
|
![]() USA
|
Market Cap | = | BTRVB.LS Stock Price | * | BTRVB.LS Shares Outstanding |
= | $114.04 | * | 50.00 M | |
= | $5.70 B |